| Primary |
| Primary Immunodeficiency Syndrome |
28.4% |
| Premedication |
22.9% |
| Immunodeficiency Common Variable |
11.0% |
| Drug Use For Unknown Indication |
5.5% |
| Humoral Immune Defect |
3.7% |
| Immunoglobulins Decreased |
3.7% |
| Idiopathic Thrombocytopenic Purpura |
2.8% |
| Kawasaki's Disease |
2.8% |
| Off Label Use |
2.8% |
| Selective Iga Immunodeficiency |
2.8% |
| Back Pain |
1.8% |
| Demyelinating Polyneuropathy |
1.8% |
| Dermatomyositis |
1.8% |
| Pulmonary Haemorrhage |
1.8% |
| Uveitis |
1.8% |
| Blood Cholesterol Increased |
0.9% |
| Developmental Delay |
0.9% |
| Guillain-barre Syndrome |
0.9% |
| Hypertension |
0.9% |
| Hypogammaglobulinaemia |
0.9% |
|
| Drug Intolerance |
27.5% |
| Myocardial Infarction |
12.5% |
| Tremor |
7.5% |
| Vomiting |
7.5% |
| Hiv Antibody Positive |
5.0% |
| Transient Ischaemic Attack |
5.0% |
| Deep Vein Thrombosis |
2.5% |
| Glomerulonephritis Membranous |
2.5% |
| Haemolytic Anaemia |
2.5% |
| Hypertension |
2.5% |
| Ischaemic Stroke |
2.5% |
| Light Chain Analysis Increased |
2.5% |
| Meningitis Aseptic |
2.5% |
| Neutropenia |
2.5% |
| Ocular Myasthenia |
2.5% |
| Pancreatitis Acute |
2.5% |
| Platelet Count Increased |
2.5% |
| Pyrexia |
2.5% |
| Renal Failure Acute |
2.5% |
| Thrombophlebitis |
2.5% |
|
| Secondary |
| Primary Immunodeficiency Syndrome |
14.5% |
| Extranodal Nk/t-cell Lymphoma, Nasal Type |
12.9% |
| Premedication |
12.1% |
| Demyelinating Polyneuropathy |
8.6% |
| Erdheim-chester Disease |
5.9% |
| Prophylaxis |
5.9% |
| Immunodeficiency Common Variable |
5.1% |
| Kawasaki's Disease |
5.1% |
| Pneumonia |
4.7% |
| Renal Transplant |
4.7% |
| Hypertension |
4.3% |
| Selective Iga Immunodeficiency |
3.1% |
| Hypothyroidism |
2.0% |
| Off Label Use |
2.0% |
| Benign Prostatic Hyperplasia |
1.6% |
| Dermatomyositis |
1.6% |
| Diabetes Prophylaxis |
1.6% |
| Humoral Immune Defect |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Polyneuropathy |
1.6% |
|
| Drug Intolerance |
28.3% |
| Myocardial Infarction |
13.0% |
| Drug Ineffective |
8.7% |
| Hepatitis C Positive |
4.3% |
| Herpes Virus Infection |
4.3% |
| Myocardial Ischaemia |
4.3% |
| Paralysis |
4.3% |
| Transplant Abscess |
4.3% |
| Tremor |
4.3% |
| Ascites |
2.2% |
| Bronchopulmonary Aspergillosis |
2.2% |
| Convulsion |
2.2% |
| Glomerulonephritis Rapidly Progressive |
2.2% |
| Hepatitis C |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Hypertension |
2.2% |
| Kidney Transplant Rejection |
2.2% |
| Menorrhagia |
2.2% |
| Migraine |
2.2% |
| Ocular Myasthenia |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.3% |
| Drug Use For Unknown Indication |
14.1% |
| Osteoporosis |
8.5% |
| Idiopathic Thrombocytopenic Purpura |
7.8% |
| Systemic Lupus Erythematosus |
6.4% |
| Prophylaxis Against Graft Versus Host Disease |
6.3% |
| Infection Prophylaxis |
4.9% |
| Heart Transplant |
3.3% |
| Meningitis |
3.3% |
| Kawasaki's Disease |
3.1% |
| Prophylaxis |
3.0% |
| Rheumatoid Arthritis |
3.0% |
| Mantle Cell Lymphoma |
2.4% |
| Multiple Myeloma |
2.4% |
| Autoimmune Neutropenia |
2.1% |
| Autoimmune Thrombocytopenia |
2.1% |
| Graft Versus Host Disease |
2.1% |
| Immunosuppression |
2.1% |
| Anxiety |
1.9% |
| Epilepsy |
1.9% |
|
| Wound Infection Staphylococcal |
15.7% |
| Sepsis |
11.1% |
| Withdrawal Of Life Support |
8.3% |
| Pneumonia |
6.5% |
| Wound Secretion |
5.6% |
| Febrile Neutropenia |
4.6% |
| Systemic Mycosis |
4.6% |
| Thrombocytopenia |
4.6% |
| Weight Decreased |
4.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.7% |
| Myelodysplastic Syndrome |
3.7% |
| Subcutaneous Emphysema |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Burning Sensation |
2.8% |
| Drug Ineffective |
2.8% |
| Electroencephalogram Abnormal |
2.8% |
| Epstein-barr Virus Infection |
2.8% |
| Lung Disorder |
2.8% |
| Neuroleptic Malignant Syndrome |
2.8% |
| Paraesthesia |
2.8% |
|
